Product Code: ETC8854326 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The viral vector and vaccine market is critical for public health in the Philippines, particularly in combating infectious diseases like COVID-19, dengue, and hepatitis. This market encompasses the development, production, and distribution of viral vector-based vaccines, with local and international collaborations driving growth.
The viral vector and vaccine market is growing as advancements in biotechnology lead to the development of innovative vaccines. Viral vectors are used in the production of vaccines, including COVID-19 vaccines, creating significant opportunities for the market in the Philippines.
This market faces challenges including the complex nature of viral vector design, high R&D costs, regulatory hurdles, and logistical difficulties in vaccine distribution across the archipelago. Public skepticism toward new vaccines can also slow market adoption.
The Philippines Viral Vector and Vaccine market is expanding due to the growing demand for innovative vaccines and gene therapies. Viral vectors are increasingly being used in vaccine development, as they can deliver targeted genetic material to induce an immune response. This market offers significant investment opportunities in the development, production, and distribution of viral vector-based vaccines, particularly as the country looks to enhance its biotechnology capabilities in response to emerging infectious diseases.
Philippine health policy prioritizes vaccine security, with the National Immunization Program and the planned Virology and Vaccine Institute of the Philippines spearheading research and production. The FDA regulates vaccine trials and approvals, while government procurement policies aim to ensure affordable and equitable vaccine distribution.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Viral Vector and Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Viral Vector and Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Philippines Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Philippines Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Viral Vector and Vaccine Market Trends |
6 Philippines Viral Vector and Vaccine Market, By Types |
6.1 Philippines Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.4 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2021- 2031F |
6.1.5 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2021- 2031F |
6.1.6 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2021- 2031F |
6.2 Philippines Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.2.3 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.2.4 Philippines Viral Vector and Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Viral Vector and Vaccine Market Export to Major Countries |
7.2 Philippines Viral Vector and Vaccine Market Imports from Major Countries |
8 Philippines Viral Vector and Vaccine Market Key Performance Indicators |
9 Philippines Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Philippines Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Philippines Viral Vector and Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |